The government welcomes foreign firms, but its tax regime draws criticism.
There's consensus that the tax systems needs revising. Beyond that, a void.
The Treasury Secretary also made his case for the U.S. leading the global economy.
We went to the treasury to talk inversions, MetLife, America's place in the global economy and — of course — the $10 bill.
Nela Richardson and David Gura join Molly to recap the week that was.
The Pfizer-Allergan merger is out, but what about inversions across the board?
The Treasury Department issues new rules to deter U.S. corporations from merging with foreign companies for tax purposes.
Companies sidestep taxes that support Medicare or Medicaid, then sell those programs drugs.
Regulators want to cut down on these deals, but this one is full-speed ahead.
The deal would create the largest pharmaceutical company in the world.
